Security record · archived quarter
GRFS
Grifols, S.A. · Healthcare · Drug Manufacturers - General
11Tracked holders
—Δ holders
43.67MShares held
$275.34MReported value
+0New positions
−0Exits
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q2 2024
Ownership over time
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 64 | -1 | 59.43M | $421.22M | +7 | −7 |
| Q1 2026 | 66 | 0 | 66.25M | $529.50M | +5 | −6 |
| Q4 2025 | 67 | 0 | 71.81M | $671.36M | +1 | — |
| Q3 2025 | 15 | 0 | 46.41M | $462.25M | — | −1 |
| Q2 2025 | 13 | 0 | 39.36M | $355.82M | — | — |
| Q1 2025 | 11 | +1 | 37.03M | $263.30M | +1 | — |
| Q4 2024 | 10 | -2 | 37.19M | $276.67M | — | −2 |
| Q3 2024 | 11 | 0 | 39.22M | $348.71M | — | — |
| Q2 2024 | 11 | — | 43.67M | $275.34M | — | — |
Who holds it · Q2 2024
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Capital World Investors ✦ | 20.89M | — | $131.71M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | Millennium Management ✦ | 13.92M | — | $87.79M | 0.1% | n/c | 1 | SEC ↗ |
| 3 | Harris Associates (Oakmark) ✦ | 3.86M | — | $24.32M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | Norges Bank ✦ (passive) | 3.31M | — | $20.85M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | Soros Fund Management ✦ | 752.00K | — | $4.74M | 0.1% | n/c | 1 | SEC ↗ |
| 6 | Point72 Asset Management ✦ | 596.85K | — | $3.76M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | Arrowstreet Capital ✦ | 143.71K | — | $906,000 | 0.0% | n/c | 1 | SEC ↗ |
| 8 | Citadel Advisors ✦ | 89.01K | — | $561,233 | 0.0% | n/c | 1 | SEC ↗ |
| 9 | Geode Capital Management ✦ (passive) | 70.80K | — | $446,387 | 0.0% | n/c | 1 | SEC ↗ |
| 10 | GAMCO Investors ✦ | 24.99K | — | $157,537 | 0.0% | n/c | 1 | SEC ↗ |
| 11 | AQR Capital Management ✦ | 14.11K | — | $88,945 | 0.0% | n/c | 1 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 1 holders, 74.05K shares, $11.87M reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
Frequently co-owned
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.
Provenance: Ownership from parsed 13F common-stock positions (tracked universe, comparable sets for changes); insider rows from Forms 3/4/5; stakes from Schedules 13D/13G; every filing links to its original on SEC EDGAR.
Reporting period: Q2 2024 ·
Methodology ·
Get this via the API